Cite

HARVARD Citation

    Howlett-Prieto, Q. et al. (2021). Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis. Multiple sclerosis. pp. 2170-2179. [Online]. 
  
Back to record